These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 1468769)

  • 21. [Normal and tumorous human gonadotropic cells].
    Trouillas J; Girod C; Loras B; Sassolas G; Claustrat B; Perrin G
    Ann Endocrinol (Paris); 1990; 51(2):54-64. PubMed ID: 2122792
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heterogeneity of secretory granules of silent pituitary adenomas.
    Holck S; Wewer UM; Albrechtsen R
    Mod Pathol; 1988 May; 1(3):212-5. PubMed ID: 3237702
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Silent subtype 3 pituitary adenomas are not always silent and represent poorly differentiated monomorphous plurihormonal Pit-1 lineage adenomas.
    Mete O; Gomez-Hernandez K; Kucharczyk W; Ridout R; Zadeh G; Gentili F; Ezzat S; Asa SL
    Mod Pathol; 2016 Feb; 29(2):131-42. PubMed ID: 26743473
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A light and electron microscopical study of pituitary adenomas.
    Stefăneanu L; Taşcă C; Coculescu M
    Endocrinologie; 1981; 19(4):243-8. PubMed ID: 7323648
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunodetection of chorionic gonadotropin and its subunits in human nonfunctioning pituitary adenomas.
    Saccomanno K; Spada A; Bassetti M; Gil-del-Alamo P; Faglia G
    J Clin Endocrinol Metab; 1994 May; 78(5):1103-7. PubMed ID: 7513714
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Morphological study of clinically nonsecreting pituitary adenomas in patients under 40 years of age.
    Yamada S; Kovacs K; Horvath E; Aiba T
    J Neurosurg; 1991 Dec; 75(6):902-5. PubMed ID: 1941118
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preoperative octreotide treatment of growth hormone-secreting and clinically nonfunctioning pituitary macroadenomas: effect on tumor volume and lack of correlation with immunohistochemistry and somatostatin receptor scintigraphy.
    Plöckinger U; Reichel M; Fett U; Saeger W; Quabbe HJ
    J Clin Endocrinol Metab; 1994 Nov; 79(5):1416-23. PubMed ID: 7962337
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The gonadotroph origin of null cell adenomas.
    Kontogeorgos G; Thodou E
    Hormones (Athens); 2016 Apr; 15(2):243-7. PubMed ID: 27376427
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An immunohistochemical and ultrastructural study of a follicle-stimulating hormone-secreting gonadotroph adenoma occurring in a 10-year-old girl.
    Tashiro H; Katabuchi H; Ohtake H; Yoshioka A; Matsumura S; Suenaga Y; Nagamura Y; Matsuura K; Okamura H
    Med Electron Microsc; 2000; 33(1):25-31. PubMed ID: 11810454
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Pathological study of 23 cases of nonfunctional pituitary adenoma].
    Zhang X
    Zhonghua Bing Li Xue Za Zhi; 1991 Mar; 20(1):47-9. PubMed ID: 2065377
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Ultrastructural and immunocytochemical study on human silent pituitary adenomas].
    Zhou XJ
    Zhonghua Yi Xue Za Zhi; 1989 Jun; 69(6):321-3, 24. PubMed ID: 2804750
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gonadotroph adenoma with secondary hypersecretion of testosterone.
    Chamoun R; Layfield L; Couldwell WT
    World Neurosurg; 2013 Dec; 80(6):900.e7-11. PubMed ID: 23201183
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pituitary tumors and hyperplasia in multiple endocrine neoplasia type 1 syndrome (MEN1): a case-control study in a series of 77 patients versus 2509 non-MEN1 patients.
    Trouillas J; Labat-Moleur F; Sturm N; Kujas M; Heymann MF; Figarella-Branger D; Patey M; Mazucca M; Decullier E; Vergès B; Chabre O; Calender A;
    Am J Surg Pathol; 2008 Apr; 32(4):534-43. PubMed ID: 18300794
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 'Silent' somatotropinoma.
    Pawlikowski M; Kuta J; Fuss-Chmielewska J; Winczyk K
    Endokrynol Pol; 2012; 63(2):88-91. PubMed ID: 22538745
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Growth hormone receptor expression and function in pituitary adenomas.
    Clausen LR; Kristiansen MT; Rasmussen LM; Billestrup N; Blaabjerg O; Ledet T; Jørgensen JO
    Clin Endocrinol (Oxf); 2004 May; 60(5):576-83. PubMed ID: 15104560
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical and ultrastructural comparison of immunohistochemically inactive and gonadotropin-producing pituitary adenomas.
    Furuhata S; Kameya T; Tsuruta T; Naritaka H
    Neurol Med Chir (Tokyo); 1995 Apr; 35(4):227-30. PubMed ID: 7596465
    [TBL] [Abstract][Full Text] [Related]  

  • 37. "Honeycomb Golgi" in pituitary adenomas: not a marker of gonadotroph adenomas.
    Sano T; Mader R; Asa SL; Qian ZR; Hino A; Yamada S
    Endocr Pathol; 2003; 14(4):363-8. PubMed ID: 14739492
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The pathology of nonfunctional pituitary adenomas.
    Martinez AJ
    Semin Diagn Pathol; 1986 Feb; 3(1):83-94. PubMed ID: 3303231
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glycoprotein hormone genes are expressed in clinically nonfunctioning pituitary adenomas.
    Jameson JL; Klibanski A; Black PM; Zervas NT; Lindell CM; Hsu DW; Ridgway EC; Habener JF
    J Clin Invest; 1987 Nov; 80(5):1472-8. PubMed ID: 2824561
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pituitary adenomas that produce adrenocorticotropic hormone and alpha-subunit: clinicopathological, immunohistochemical, ultrastructural, and immunoelectron microscopic studies in nine cases.
    Berg KK; Scheithauer BW; Felix I; Kovacs K; Horvath E; Klee GG; Laws ER
    Neurosurgery; 1990 Mar; 26(3):397-403. PubMed ID: 1690866
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.